Neurol. praxi. 2013;14(4):185-187

Gait impairment in multiple sclerosis patient

Mgr.Klára Novotná, MUDr.Jana Lízrová Preiningerová
Neurologická klinika a Centrum klinických neurověd, UK v Praze, 1. LF a VFN v Praze

Multiple sclerosis may lead to various functional impairment. Typical symptomes include decrease in muscle strength, increase in

muscle tone, sensation impairment, balance problems and loss of coordination. All these symptoms can cause gait disorders. Abnormalities

of gait that are present in almost 85–90% of patients with multiple sclerosis are present from early stages of the disease. This

article discusses typical changes of gait in patients with multiple sclerosis and the methods of quantification.

Keywords: multiple sclerosis, gait impairment, gait speed, spasticity, balance

Published: October 1, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Novotná K, Lízrová Preiningerová J. Gait impairment in multiple sclerosis patient. Neurol. praxi. 2013;14(4):185-187.
Download citation

References

  1. Benedetti MG, Piperno R, Simoncini L, Bonato P, Tonini A, Gaiannini S. Gait abnormalities in minimally impaired multiple sclerosis patients. Mul Scler 1999; 5(5): 363-368. Go to original source... Go to PubMed...
  2. Cattaneo D, Jonsdottir J. Sensory impairments in quiet standing in subjects with multiple sclerosis. Mul Scler 2009; 15(1): 59-67. Go to original source... Go to PubMed...
  3. Crenshaw SJ, Royer TD, Richards JG, Hudson DJ. Gait variability in people with multiple sclerosis. Mult Scler. 2006; 12(5): 613-619. Go to original source... Go to PubMed...
  4. Franceschini M, Rampello A, Bovolenta F, Aiello M, Tzani P, Chetta A. Cost of walking, exertional dyspnoea and fatigue in individuals with multiple sclerosis not requiring assistive devices. J Rehabil Med 2010; 42(8): 719-723. Go to original source... Go to PubMed...
  5. Gehlsen G, Beekman K, Assmann N, Winant D, Seidle M, Carter A. Gait characteristics in multiple sclerosis: progressive changes and effects of exercise on parameters. Arch Phys Med Rehabil 1986; 67(8): 536-539.
  6. Gijbels D, Dalgas U, Romberg A, de Groot V, Bethoux F, Vaney C, Gebara B, Medina CS, Maamagi H, Rasova K, de Noordhout BM, Knuts K, Feyes P. Which walking capacity tests to use in multiple sclerosis? A multicentre study providing the basis for a core set, Mult Scler 2012; 108(3): 364-371. Go to original source... Go to PubMed...
  7. Givon U, Zeolit G, Achiron A. Gait analysis in multiple sclerosis: characterization of temporal-spatial parameters using GAITRite functional ambulation system. Gait Posture 2009; 29(1): 138-142. Go to original source... Go to PubMed...
  8. Hamilton F, Rochester L, Paul L, Rafferty D, O´Leary CP, Evans JJ. Walking and talking: an investigation of cognitive-motor dual tasking in multiple sclerosis. Mult Scler 2009; 15(10): 1215-1227. Go to original source... Go to PubMed...
  9. Heesen C, Bohm J, Reich C, Kasper J, Goebel M, Gold SM. Patient perception of bodily functions in multiple sclerosis: Gait and visual function are the most valuable. Mult Scler 2008; 14(7): 988-991. Go to original source... Go to PubMed...
  10. Kaufman M, Moyer D, Bortin J. The significant change for the Timed 25-Foot Walk in the multiple sclerosis functional composite. Mult Scler 2000; 6: 4286-4290. Go to original source... Go to PubMed...
  11. Kelleher KJ, Spence W, Solomonidis S, Apatsinidis D. The characterisation of gait patterns of people with multiple sclerosis. Disabil Rehabil 2010; 32(15): 1242-1250. Go to original source... Go to PubMed...
  12. Kieseier BC, Pozzilli C. Assessing walking disability in multiple sclerosis. Mult Scler 2012; 18(7): 914-924. Go to original source... Go to PubMed...
  13. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 144-152. Go to original source... Go to PubMed...
  14. Martin CL, Philips BA, Kilpatrick TJ, Butzkueven H, Tigridy N, Macdonald E, Galea MP. Gait and balance impairment in early multiple sclerosis in the absence of clinical disability. Mult Scler 2006; 12: 620-628. Go to original source... Go to PubMed...
  15. Morris ME, Cantwell C, Vowels L, Dodd K. Changes in gait and fatigue from morning to afternoon in people with multiple sclerosis. J Neurol Neurosurg Psychiatry 2002; 72(3): 361-365. Go to original source... Go to PubMed...
  16. Nilsagard Y, Lundholm C, Gunnarsson LG, Dcnison E. Clinical relevance using timed walk tests and, timed up and go' testing in persons with multiple sclerosis. Physiother Res Int 2007; 12(2): 105-114. Go to original source... Go to PubMed...
  17. Perry J, Burnfield J. Gait analysis: Normal and Pathological Function. 2010, 2nd edition, ISBN-10: 1556427662.
  18. Perry J, Garrett M, Gronley JK, Muldou SJ. Classification of walking handicap in the stroke population. Stroke 1995; 26: 982-989. Go to original source... Go to PubMed...
  19. Schmid A, Duncan PW, Studenski S, Lai SM, Richards L, Perera S, Wu SS. Improvements in speed-based gait classifications are meaningful. Stroke 2007; 38: 2096-2100. Go to original source... Go to PubMed...
  20. Thoumie P, Lamotte D, Cantalloube S, Faucher M, Amarenco G. Motor determinants of gait in 100 ambulatory patients with multiple sclerosis. Mult Scler 2005; 11(4): 485-491. Go to original source... Go to PubMed...
  21. Zwibel HL. Contribution of impaired mobility and general symptoms to the burden of multiple sclerosis. Adv Ther 2009; 26: 1043-1057. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.